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Objective: Thoracic endovascular aortic repair (TEVAR) can be limited by inadequate proximal and distal landing zones.
Debranching or hybrid TEVARhas emerged as an importantmodality to expand landing zones and facilitate TEVAR.We
report a single-center experience with hybrid TEVAR.
Methods: We retrospectively reviewed all patients with thoracic aortic disease who received a TEVAR between February
2005 and October 2008.
Results: Forty-two patients underwent a hybrid procedure (mean age 68  13 years; 55% men). All patients were denied
open surgery due to preoperative comorbidities or low physiologic reserve; 62% had a history of coronary artery disease,
67% had chronic obstructive pulmonary disease, 61% had undergone prior aortic surgery, and 90% had an American
Society of Anesthesiology score of 4 and above. The average Society for Vascular Surgery comorbidity score was 12  2
with a range of 9 to 14. Fifty-five percent of cases were symptomatic on presentation and 83% were done emergently.
Seventy-six percent underwent debranching of the aortic arch, 17% of the visceral vessels, and 7% required both. Primary
technical success was achieved in all cases and of these, 43% were staged. The 30-day mortality was 5%. Myocardial
infarction developed in 5%, respiratory failure in 31%, cerebrovascular accident (stroke or transient ischemic attack) in
19%, and spinal cord ischemia with ensuant paraplegia occurred in 5% of patients. Fifty-eight percent of patients were
discharged home, 11% required rehabilitation, and 29% were transferred to a skilled nursing facility. There was a
significant association between visceral vessel debranching and both spinal cord ischemia (P .004) and gastrointestinal
complications (P .005). On the other hand, there was no difference between staged and non-staged hybrid procedures.
Conclusions: Hybrid procedures can successfully extend the range of patients suitable for a subsequent TEVAR. These
procedures are associated with higher complication rates than isolated infrarenal or thoracic endovascular repair, but
given the medical and anatomical complexity of these patients, the current results are quite encouraging. (J Vasc Surg
2010;51:259-66.)There has been an increase in the reported incidence of
all aortic aneurysms, likely secondary to improvements in
awareness, screening, and imaging. If left untreated, the
risk of mortality due to rupture for thoracic and thoraco-
abdominal aortic (TAA) aneurysms6 cm is 12% per year,
and if given medical treatment alone, up to 50% of these
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doi:10.1016/j.jvs.2009.09.043patients can be expected to die within 5 years.1 The estab-
lished gold standard of therapy is open surgical repair, but
the reported morbidity and mortality is still high. In the
United States, mortality in national datasets is 10% over-
all and 18% if ruptures are included,2,3 whereas in
high-volume single-institution series, it is lower.4 The
popularity of endovascular stent grafting has been in-
creasing exponentially, since several studies showed feasibility
and lowermorbidity andmortality rates of endovascular treat-
ment compared to open repair.5,6 Extensive thoracic and
thoracoabdominal aortic aneurysms, particularly those involv-
ing the arch or viscero-renal vessels, are associated with sub-
stantial surgery-relatedmorbidities, yet are often anatomically
unsuitable for endovascular repair due to inadequate landing
zone(s).7,8 A balance needs to be drawn between the
morbidity of open surgery and the physiological reserves
of the patient. The hybrid thoracic endovascular aortic
repair (TEVAR) approach combining techniques of arch
and viscero-renal artery debranching or translocation with
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as a potential tool to extend the envelope of intervention in
those patients with a poor physiological reserve.9 This was
reflected in promising early results reviewed by Donas et al,
who reported 100% technical success, 10.7% 30-day mortal-
ity, and absence of paraplegia.10 The aim of our study is to
share our extensive experience, focusing on an analysis of
outcomes for debranching of the thoracic and abdominal
territories and of concomitant vs staged approaches.
METHODS
Study design. We performed a retrospective analysis
of records of all patients who underwent TEVAR at The
Methodist Hospital (Houston, Texas, USA) between Feb-
ruary 2005 andOctober 2008. We specifically reviewed the
subset of patients who underwent debranching of the aorta
prior to TEVAR to improve inadequate landing zone(s).
Patients’ demographics, preoperative comorbidities, his-
tory of prior aortic surgery, and indication for surgery were
collected. Details of the procedure including approach,
technique, graft type, number of devices used, delivery
methods, intraoperative complications and challenges, op-
erative time, and technical success were recorded. Postop-
erative hospital course, morbidity, and mortality were as-
sembled and categorized by systems. For the purpose of
analysis, patients were divided into groups according to
their debranching site (ie, arch, visceral, and combined).
Further analysis was performed, and patients were grouped
according to whether the debranching was done in combi-
nation with immediate (non-staged) or delayed (staged)
endovascular repair. The patients’ status after discharge was
followed through clinic records, and survival was confirmed
by querying the Social Security Death Index. This study
was approved by Institutional Review Board.
Treatment algorithm. All patients presented with
thoracic or thoracoabdominal aortic disease that was evi-
dent on computed tomographic (CT) scans. Indications for
intervention were symptomatic thoracoabdominal aneu-
rysm or dissection, thoracoabdominal aneurysm 6.5 cm,
Type A dissections with extension into the arch and de-
scending aorta, and Type B dissections that failed medical
management. Patients with an age 80 years, oxygen-
dependent chronic obstructive airway disease, exercise-
limiting cardiomyopathy, emergency cases, and redo aortic
procedures were considered for hybrid procedures. Patients
had to have at least a 6 month expected life expectancy
based on the senior surgeon’s opinion and had to have
either a healthy descending or infra renal aorta as a donor
site for the branch grafts or underwent an aortic replace-
ment (ie, aortobifemoral graft) to facilitate branch grafting.
The patients were not considered suitable for conventional
open surgical repair due to severe preoperative comorbidi-
ties and low physiologic reserve. This was quantitated using
the Society of Vascular Surgeons (SVS) aneurysm co-
morbidity score.11 At the same time, none of the patients
was found to be a candidate for endovascular treatment
alone due to inadequate landing zone(s)8 and were there-
fore offered a hybrid procedure. The aortic debranchingprocedure was performed by a multispecialty team of car-
diothoracic and vascular surgeons followed by either imme-
diate (non-staged) or delayed (staged) endovascular exclu-
sion. Multiple approaches were used, which were dictated
by the presence of comorbid conditions, the location and
extent of the aneurysm, and history of previous aortic
surgery. The patients that required aortic arch revascular-
Fig 1. Schematic demonstrations showing A: Arch vessels de-
branching using 14-mm inflow conduit from ascending aorta
followed by 10-mm bypass graft to the innominate, left common
carotid and left subclavian arteries; B: Arch vessels debranching
using 10-mm dacron graft with retrograde inflow through 10-mm
graft. Endograft was delivered using 14-mm conduit. Copyright to
the Department of Cardiovascular Surgery, Methodist DeBakey
Heart & Vascular Center.ization were approached through standard sternotomy,
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ular approach with extension of the incision along the
anterior border of the left sternocleidomastoid muscle.
Cases with ascending aortic reconstruction required cardio-
pulmonary bypass, while in the remaining cases, a proximal
partial occlusion clamp technique was used. Inflow was
obtained from the ascending aorta in most cases (Fig 1A).
In one case, inflowwas achieved from the descending aorta.
(Fig 1B) Electroencephalography (EEG) or transcranial
Doppler (TCD) was used for cerebral monitoring as avail-
able. In those patients who underwent visceral revascular-
ization, the approach was through a midline laparatomy.
Patients with aorto-iliac disease underwent aorto-bifemoral
(ABF) bypass prior to debranching. Special attention was
paid to create 5-cm infrarenal landing zones and larger
(22-mm) Dacron grafts were used with one of the ABF
bypass limbs extended to the groin to allow subsequent
introduction of the stent grafts. Spinal drain was used as
spinal cord protection in all patients with previous thoraco-
abdominal aortic repair and where the device crossed the
diaphragm or the sixth thoracic vertebra. In patients with
concomitant or prior aortic reconstructions, inflow was ob-
tained from aortic grafts, and in one case from the ascending
aorta (Figs 2 and 3). Patients who required arch and viscero-
renal debranching underwent a combination of the two pro-
cedures explained above through sternotomy and laparatomy
incisions (Fig 3). The visceral graft was tunneled in the retro-
Fig 2. Schematic demonstrations showing visceral debranching
after Aorto-Bifemoral Bypass, followed by right limb to right renal
and right superior mesenteric artery and left limb to left renal and
common hepatic bypass. Copyright to the Department of Cardio-
vascular Surgery, Methodist DeBakey Heart & Vascular Center.sternal space and then brought through the diaphragm andbehind the left lobe of the liver and into the lesser sac for access
to the celiac and through the transverse mesocolon to the
superior mesenteric artery (SMA).
Debranching was performed using multi-branched Da-
cron grafts ranging from 8 mm to 10 mm in size, and the
grafts were sutured to the arch or visceral vessels in an end-to-
end fashion. In all cases, endovascular aneurysm exclusionwas
performed using the Gore TAG device (W. L. Gore & Asso-
ciates, Inc., Flagstaff, Arizona, USA). The grafts were deliv-
ered either in an antegrade fashion through a limb of the
debranching graft in selected patients who received concom-
itant endovascular repair, or in a retrograde fashion through
femoral access or conduit. At the end of all procedures, a
completion angiogram was performed (Fig 4).
Definitions. The baseline serum creatinine was the
value recorded closest to the procedure. An elevated creat-
inine was defined as 1.4 mg/dl. End-stage renal disease
was defined as need for hemodialysis. Emergency surgery
was defined as rupture or acute aortic syndrome necessitat-
ing operative repair within 24 hours. Intraoperative com-
plications were defined as bleeding, dissection, perforation,
acute aortic occlusion, migration, or endoleak. To docu-
ment the site of the proximal landing zone of the endograft
during thoracic endovascular procedures, we have used an
anatomic classification system used by Criado et al.12 Tech-
nical success was defined as successful revascularization and
exclusion of the aortic lesion in the absence of a type I and
Fig 3. Schematic demonstrations showing arch and visceral de-
branching, inflow obtained from ascending aorta. Copyright to the
Department of Cardiovascular Surgery, Methodist DeBakey Heart
& Vascular Center.III endoleak at the end of the procedure. Major postoper-
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respiratory failure (24 hours intubation), acute renal fail-
ure (an increase of serum creatinine to 2.0 or 20%
baseline creatinine or a new requirement for dialysis), gas-
trointestinal ischemia, cerebrovascular accidents, transient
spinal cord ischemia, and permanent paraplegia. A death
within 30 days of the procedure was considered procedure-
Fig 4. Completion angiography after stent grafting in a patient
that underwent arch and abdominal debranching shows the pa-
tency of bypass grafts and the exclusion on the aneurysm.related. Procedure-related morbidities were defined as anynew cardiac, pulmonary, neurological, infectious, or renal
systemic complication that required intervention or halted
discharge. A composite endpoint of either death or perma-
nent paraplegia 30 days was also calculated. All data are
presented in accordance with the “Reporting Standards for
Endovascular Aortic Aneurysm Repair’’ of the Ad Hoc
Committee for Standardized Reporting Practices in Vascu-
lar Surgery of The Society for Vascular Surgery/American
Association for Vascular Surgery.11
Statistical analysis. Data were analyzed by a statisti-
cian in The Methodist Hospital Research Institute using
STATA software version 10 (Stata Corp LP 2007, College
Station, Tex). Data are presented as means  standard
deviations for continuous variables or numbers and per-
centages for categorical variables. Tests for difference be-
tween groups and subgroups were based on Fischer’s Exact
Test or Chi-square test.
RESULTS
From a total of 155 patients who underwent TEVAR,
42 underwent a hybrid TEVAR procedure. The mean age
of these hybrid patients was 68  13 years and 55% were
male. The principal indications for surgery were aortic
aneurysm in 78% and dissection in 17 % (Table I). The
average aneurysm size was 6.7  0.4 cm. Fifty-five percent
of the patients were symptomatic on presentation, and 17%
of cases were done emergently. All patients were deemed
too high risk for open surgery with 89% of patients having
an American Society of Anesthesiologists (ASA) score of 4
or higher. Comorbidities included 38% coronary artery
disease, 33% chronic obstructive pulmonary disease, 19%
congestive heart failure, 24% cerebrovascular disease, and
39% had undergone prior aortic surgery. The average SVS
comorbidity score was 12 2 with a range of 9 to 14. The
indication for a hybrid procedure over conventional endo-
vascular procedure included: 83% with inadequate proxi-
mal landing zones (31% zone 0, 12% zone 1, 23% zone 2,
7% zone 3, 9% zone 4) and 24% with inadequate distal
landing zones (of which 64% had renal artery involvement).
Seven percent had both inadequate proximal and distal
landing zones.
Various surgical techniques were used to perform a
hybrid approach and achieve a satisfactory landing zone(s)
Table I. Indications
Indication n (%) Classification n (%)
Aneurysm 33 (78) Thoracic 22 (52)
TAA 11 (26)
Dissection 7 (17) Stanford A 3 (7)
Stanford B 4 (10)
Acute 4 (10)
Chronic 3 (7)
Other 2 (5) PAU 1 (2)
IMH 1 (2)
AAA, Abdominal aortic aneurysm; IMH, intramural hematoma; PAU,
penetrating aortic ulcer; TAA, thoracoabdominal aortic.(Table II). Among the 35 patients with inadequate proxi-
ommo
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bypass, 5 patients received ascending aortic replacement
with valve suspension followed by debranching of the aorta,
and three patients received arch reconstruction with ele-
phant trunk creation. In one patient, a retrograde inflow to
the arch vessels was obtained from the descending aorta; in
all other cases, the inflow was antegrade. As for the seven
patients with inadequate distal landing zones, in two cases
antegrade inflow to visceral vessels was obtained from the
ascending aorta, and in the remainder, flow was retrograde.
Concomitant endovascular repair was performed in
55% of cases; the rest were repaired as a staged procedure.
The average number of GORE TAG endografts used was
two (range, one to five devices). In 13% of the cases, the
endografts were delivered in antegrade fashion through a
limb of the debranching graft, and in 87%, the devices were
delivered in a retrograde fashion through either the femoral
or iliac arteries (26% of the cases required the use of a
conduit due to inadequate vessel structure).
Outcome. Technical success was achieved in 100% of
cases. Thirty-day mortality was 5%; the causes for mortality
were myocardial infarction on postoperative day one in one
patient, bleeding complicatedby sepsis in one patient, sepsis in
one patient, and stroke in one patient whose family withdrew
care on day 15when he did not show improvement.Mortality
was 17% at 2 year follow-up.One-third of the deaths in follow
up could be attributed to the procedure or postoperative
complications associated with the procedure.
Five percent of patients developed myocardial infarc-
tion, 31% developed respiratory failure, of which 19% re-
quired tracheostomy. Seven percent developed prolonged
ileus and 5% bowel ischemia, 14% developed renal failure,
while 19% had cerebrovascular accidents. Five percent of
patients had spinal cord ischemia with subsequent paraple-
gia on discharge. The composite endpoint of death and or
permanent paraplegia at 30 days was 4.8%.
The average length of stay was 16  10 days. Fifty-eight
percent of the patients were discharged home, 11% required
rehabilitation, and 29% went to a skilled nursing facility.
When the outcome was examined based on the de-
branching site, there was a significant association between
Table II. Adjunctive surgical procedures performed to cre
Debranching site n (%) Proce
Arch 32 (76) Asc Ao -Innom/RCCA, RCCA
RCCA-LCCA, LCCA-LSCA
LCCA-LSCA
Asc Ao replacement/completio
Asc Ao- R Verebral & RCCA (
Visceral 7 (17) RI- RRA & SMA, LI-LRA & C
ABF, Limb- RRA, Limb- SMA
Both 3 (7) LCCA-RCCA, RI- RRA & SM
Asc Ao- Graft, Graft- RCCA, L
ABF, Aorto-bifemoral bypass; Asc Ao, ascending aorta; CHA, common hep
iliac; LRA, left renal artery; LSCA, left subclavian artery; RCCA, right c
mesenteric artery.visceral vessel debranching and both spinal cord ischemiaprobably reflecting coverage of the critical visceral area of
the aorta (P  .004) and gastrointestinal complications
(P  .005) (Table III). On the other hand, there was no
difference in outcomes between staged and non-staged
hybrid procedures (Table IV). Similarly, if outcome is
reported by etiology, there was no difference between
dequate landing zone
description Procedures n (%)
CA, LCCA-LSCA
phant trunk
arch)
13 (31)
7 (17)
7 (17)
3 (7)
2 (5)
/CHA
b- LRA, Limb- Celiac/CHA
2 (5)
5 (12)
-LRA & Celiac/CHA
, LSCA, SMA, Celiac/Splenic artery
1 (2)
2 (5)
tery; Innom, innominate artery; LCCA, left common carotid artery; LI, left
n carotid artery; RI, right iliac; RRA, right renal artery; SMA, superior
Table III. Complications stratified by debranching
type (%)
Complication
Arch
(n  32)
Visceral
(n  7)
Both
(n  3) P value
MI 3% 14% 0% .49
Respiratory failure 28% 43% 33% .74
Renal failure 13% 14% 33% .62
GI 3% 57% 0% .004
SCI 0% 29% 0% .005
CVA/TIA 22% 0% 33% .33
Death (30 days) 3% 0% 33% .051
Composite endpoint 3% 0% 33% .051
CVA, Cerebrovascular accident; GI, gastrointestinal;MI,myocardial infarc-
tion; SCI, spinal cord ischemia; TIA, transient ischemic attack.
Composite endpoint is the combined death and permanent paraplegia rate at
30 days.
Table IV. Comparison of the outcome of non-staged
and staged procedures (%)
Complication
Hybrid
non-staged
(n  24)
Hybrid
staged
(n  18)
P
value
MI 0% 11% .17
Respiratory failure 17% 44% .08
Renal failure 21% 6% .21
GI 17% 6% .37
SCI 4% 6% 1.0
CVA/TIA 21% 18% 1.0
Death (30 days) 8% 0% .49
Composite endpoint 13% 6% .62
CVA, Cerebrovascular accident; GI, gastrointestinal;MI,myocardial infarc-
tion; SCI, spinal cord ischemia; TIA, transient ischemic attack.
Composite endpoint is the combined death and permanent paraplegia rate at
30 days.ate a
dure
-LC
n ele
right
eliac
, Lim
A, LI
CCA
atic araneurysmal disease and dissection (Table V).
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Endovascular aortic treatment is gradually replacing open
repair, as clinical results are supporting its safety and effective-
ness. In a recent comparison of the 5-year results of endovas-
cular and open aortic repair, Makaroun and colleagues
showed that in anatomically suitable patients, endovascular
treatment of thoracic aneurysms is superior to surgical repair.6
Still, endovascular treatment has anatomical limitations and
exposes the patients to extensive radiation times and lengthy
procedures. Extensive aortic aneurysms, particularly involving
the arch or visceral vessels, present a dilemma, asmany of these
patients are aged as well as having comorbidities precluding
standard open repair. Unfortunately, the aortic pathology is
often anatomically unsuitable for endovascular repair, which
requires coverage of the aortic arch vessels or the risk of
compromising the viscero-renal vessels. The current fenes-
trated and branched endografts are technically demanding
from both a design and deployment perspective and are only
available in the US under a manufacturer or physician-spon-
sored investigational study.2,13 Theongoing effort to improve
outcomes after thoracoabdominal aortic aneurysm (TAAA)
repair has led to the development of a hybrid approach that
combinedopen and endovascular techniques. Thisminimized
the open procedural burden and at the same time increased
the number of patients that can benefit from endovascular
repair.14-17 In our experience, 27% of the referred patients
were offered hybrid procedures during the last 3 years.
This report demonstrates that hybrid procedures can suc-
cessfully extend the range of patients suitable for a subsequent
TEVAR; however, the procedures are associated with higher
complication rates than isolated infra-renal or thoracic endo-
vascular repair. This level of morbidity has been seen in mul-
tiple other studies and should be considered before interven-
tion.18 The current criteria in the literature for a hybrid
procedure are age 70 high-risk patients with contraindica-
tions to open surgery (eg, oxygen dependent COPD, cardio-
myopathy), emergency cases and redo aortic procedure and a
healthy descending or infrarenal aorta as a donor site for the
Table V. Comparison of the outcome of aneurysm and
dissection (%)
Complication
Hybrid
aneurysm
(n  33)
Hybrid
dissection
(n  7)
P
value
MI 6% 0% 1
Respiratory failure 33% 20% .65
Renal failure 15% 20% 1
GI 24% 0% .38
SCI 15% 0% .56
CVA/TIA 18% 40% .61
Death (30 days) 24% 0% .31
Composite endpoint 13% 0% .07
CVA, Cerebrovascular accident; GI, gastrointestinal;MI,myocardial infarc-
tion; SCI, spinal cord ischemia; TIA, transient ischemic attack.
Composite endpoint is the combined death and permanent paraplegia rate at
30 days.branch grafts. The SVS comorbidity scores in this series arehigh, correlatewith theASAgrading and reflect the severity of
comorbidity in the patients. A 5% overall mortality rate is at
the lower end of the spectrum of data reported by others for
hybrid series and likely reflects the senior clinical surgeons’
experience and the fact that while hybrid surgery can be
successfully performed in most patients, the natural history of
the patient’s overall disease is taken into account before we
advise that the patient undergoes surgery.18,19
It is often recognized that one of the main benefits of the
hybrid approach is the lack of aortic cross-clamping reducing
renal and visceral and ischemia.20 This is underlined by Sarac
et al, who compared their results of suprarenal and supravis-
ceral clamping and found that supraceliac clamping was asso-
ciated with greater mortality (11.6% vs. 2.1%) and postopera-
tive renal insufficiency (42% vs. 22%) than was suprarenal
clamping.21 In our visceral debranching group, we did not
have any mortality, and renal failure was seen in 14% of that
group. However, two patients developed prolonged ileus and
two others developed bowel ischemia despite the patency of
bypass grafts. This highlights the fact that there are potentially
other contributing factors, such as operative time, intraoper-
ative hypotension, and the extent of atherosclerotic disease.
Despite the advantages of less surgical exposure, avoid-
ance of aortic cross-clamping and reduced tissue ischemia, the
endovascular technique lacks the opportunity to revascularize
the spinal vessels.22,23 Nevertheless, low paraplegia rates have
been reported by numerous authors10 including Lee, who
despite reporting high mortality and morbidity rate of 24%
and 25%, respectively, had no cases of paraplegia.24 Alterna-
tively, some authors do not recommend a hybrid procedure
for extent IV TAAA aneurysms or previous infra-renal aortic
repair.14,15 In our study, twopatients in the visceral debranch-
ing group developed spinal cord ischemia (SCI) and subse-
quent paraplegia; one of the patients’ diagnoses was type I
TAAA and the other was type IV TAAA. That accounts for
one out of the three extent IVTAAApatients in our study that
developed SCI. Neither of the two patients had previous
aortic surgery, and one of themdeveloped SCI despite the use
of protective mechanisms such as CSF drain and blood pres-
sure adjustments. Interestingly, both patients had a history of
chronic kidney disease (one was a hemodialysis dependent),
which is related to a higher complication rate after open or
endovascular treatment, including SCI. Wang and colleagues
recently reviewed 390 patients with renal failure who under-
went TEVAR and found that there is a two-fold (4.8% vs.
2.4%) increased risk of developing SCI in patients with creat-
inine1.5.25 On the other hand, Gravereaux showed signif-
icant correlation between long-segment thoracic aortic exclu-
sion and paraplegia.26 The two patients in our study who
became paraplegic were treated with two and three TAG
GORE devices, respectively. Nineteen percent of the patients
had cerebrovascular accidents, and all were in the arch hybrid
group. This group included both Type A dissections and arch
aneurysms. Overall, in hybrid procedures for arch aneurysms,
the 30-day stroke rate ranges up to 20%.18 This remains an
important problem and adds significantly to the morbidity
and final disposition status of the patient.
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invasive. In many cases, the procedures still involve large
incisions, including sternotomies and/or laparatomies.
Baldwin and colleagues described the double-barrel tech-
nique that permits complete aortic arch coverage without a
sternotomy,27 but the feasibility and long-term durability
remains unknown. In an effort to avoid sternotomies, es-
pecially in patients with prior cardiac surgery, we developed
the “mini” thoracotomy approach, which was previously
described by our group.28 (Fig 5). This approach allows
supra-aortic trunk debranching through an anterior thora-
cotomy followed by endovascular repair of a large proximal
arch aneurysm. In this study, that approach was used in four
patients with 100% technical success. As for the visceral
debranching, Bakoyiannis et al recently described a totally
laparoscopic aorto-hepatic bypass for a hybrid procedure to
repair a Crawford type III TAAA and another laparoscopic-
assisted debranching of a renal artery during AAA re-
pair.29,30 This approach could potentially make the hybrid
Fig 5. Mini Thoracotomy. A: Right anterolateral “mini” thora-
cotomy incision combined with supraclavicular incision and an-
teromedial sternocleidomastoid incison extension during arch de-
branching in a patient with previous sternotomy. B: Post operative
picture shows healed incisions.procedure truly a minimally invasive one.Based on this experience, we have adopted the follow-
ing approach for hybrid procedures. For establishment of
proximal landing zones, we take the least invasive approach.
Left carotid-subclavian bypass with proximal subclavian
embolization is performed if the subclavian artery is cov-
ered. In cases where the left carotid and subclavian arteries
are covered, we perform a carotid-carotid bypass with a left
carotid-subclavian bypass followed by ligation of the prox-
imal left carotid and embolization of the proximal subcla-
vian artery. If the innominate origin is covered, we add an
ascending aorto-right common carotid bypass and ligate
the innominate below the confluence; this is followed with
a carotid-carotid and left carotid-subclavian bypass as de-
scribed. We now perform the aorto-carotid bypass through
a right anterior throacotomy using minimally invasive tech-
niques. For establishment of distal landing zones, we per-
form renal and visceral bypasses either from the aorta, iliacs,
or graft limbs with provision of an aortofemoral conduit for
subsequent TEVAR access. These procedures are generally
performed 3 to 5 days before a thoracic endograft is placed.
If both proximal and distal landing zones are needed to be
lengthened with a hybrid procedure, we would wait 14 to
30 days with the abdominal hybrid preceding the thoracic
hybrid procedure.
Many potential advantages of non-staged over staged
approaches have been described, including prompt avail-
ability of the iliac axis or infrarenal aorta for endograft
insertion, ability to visualize the abdominal vascularization
during stent deployment,31 lower overall operative time,
which is usually associated with lower complications, and
stabilization of spinal cord perfusion.15 Others showed
concerns about risk of aneurysm rupture, embolic occlu-
sion/thrombosis of graft branches,15 or potential harm to
the proximal anastomosis of the bypass grafts.14 Neverthe-
less, none of these studies were able to provide data in favor
of the staged approach.14,15,31,32 In our experience, the
staging decision reflects a clinical judgment at the time of
the procedure. Particularly with abdominal debranching,
we exclusively use the staged approach due to the exten-
sive nature of the procedure that includes difficult dis-
sections and challenging anastomosis and the associated
intraoperative coagulopathies and high patient burden.
Based on those decisions, we invariably offered staged
procedures to the most debilitated patients, but due to
the retrospective nature of this analysis, we have no way
of ascertaining completely whether or not this was ben-
eficial in preventing any untoward complications. This
emphasizes the value and need for determining in a
prospectively randomized manner, which patients will
benefit the most from a hybrid procedure, as well as
describing which operative decisions are worthwhile.
Although formulating a paradigm for aortic debranching
would be helpful, such a prospective randomized trial is
unlikely to ever be performed.
CONCLUSION
Hybrid procedures can successfully extend the range
of patients suitable for a TEVAR. Mortality and morbid-
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debilitated patients, which suggests that further studies
to identify the patients best suited for hybrid TEVAR are
required. Undoubtedly, these procedures are associated
with higher complication rates than isolated infrarenal or
thoracic endovascular repair, but given the medical and
anatomical complexity of these patients, we find results
for these cases quite encouraging.
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